CD133 shapes extracellular vesicle cargo and angiogenic function in basal-like triple-negative breast cancer
Authors:
- Mireia Gomez-DuroMGMireia Gomez-Duro
- Ptissam BergamPBPtissam Bergam
- Lorena Martin-JaularLMLorena Martin-Jaular
- Sara Sanchez-RedondoSSSara Sanchez-Redondo
- Marta Hergueta-RedondoMHMarta Hergueta-Redondo
- Florent DingliFDFlorent Dingli
- Damarys LoewDLDamarys Loew
- Hector PeinadoHector Peinado
- Thierry DuboisTDThierry Dubois
- Graça RaposoGRGraça Raposo
- Gisela D’angeloGDGisela D’angelo
Preprint
Abstract
Extracellular vesicles (EVs) are central mediators of tumor-stroma communication, yet the mechanisms governing their biogenesis and functional cargo remain poorly understood. Here, we identify CD133 (Prominin-1), selectively expressed in basal-like triple-negative breast cancer (BL-TNBC) cells, as a key regulator of EV production and cargo composition. CD133 localizes to plasma membrane protrusions and lipid rafts, maintaining membrane architecture, promoting EV release, and shaping selective protein loading, including the pro-angiogenic factor CD105. Functionally, CD133⁺ EVs potently induce endothelial tubulogenesis in a CD105-dependent manner, independently of EV uptake or endothelial proliferation. In vivo , these EVs preferentially accumulate in the lung and liver, highlighting organ-specific communication. Mechanistically, CD133 maintains lipid raft integrity, facilitating CD105 selective incorporation into vesicles, thereby establishing a spatially coordinated CD133-CD105 axis. Together, our findings define a subtype-specific EV population whose identity and angiogenic activity are dictated by membrane organization. By linking protrusion architecture to vesicle-mediated signaling, this study highlights CD133-enriched EVs as potential biomarkers and therapeutic targets in aggressive BL-TNBC.Keywords
Funding Information
- Fondation ARC pour la Recherche sur le Cancer (PJA2024070008456)
- La ligue contre le cancer (RS25/75-81)
- European Union, EVCA Twining Project
- European Unionșs Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie (Grant agreement No 847718)
This publication has 68 references indexed in Scilit:
- Correction to “Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches”Journal of Extracellular Vesicles, 2024
- Diverse plasma membrane protrusions act as platforms for extracellular vesicle sheddingJournal of Extracellular Vesicles, 2021
- Prominin-1/CD133: Lipid Raft Association, Detergent Resistance, and ImmunodetectionStem Cells Translational Medicine, 2017
- Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of MetastasisCancer Cell, 2016
- Fast and Accurate Protein False Discovery Rates on Large-Scale Proteomics Data Sets with Percolator 3.0Journal of the American Society for Mass Spectrometry, 2016
- Cancer-Secreted miR-105 Destroys Vascular Endothelial Barriers to Promote MetastasisCancer Cell, 2014
- Lipid raft regulates the initial spreading of melanoma A375 cells by modulating β1 integrin clusteringThe International Journal of Biochemistry & Cell Biology, 2013
- MassChroQ: A versatile tool for mass spectrometry quantificationProteomics, 2011
- my ProMS, a web server for management and validation of mass spectrometry‐based proteomic dataProteomics, 2007
- Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological FluidsCurrent Protocols in Cell Biology, 2006